Navigation Links
ESPN's Dick Vitale and Michael Wilbon Stand Up in the Fight Against Prostate Cancer
Date:12/4/2008

of Stand Up To Cancer and its innovative research-support efforts.

Additional supporters and in attendance at the 'Life: Interrupted' town hall event include the American Urological Association Foundation, CancerCare, Men's Health Network, Prevent Cancer Foundation, Prostate Cancer Education Council, Prostate Cancer Foundation, UsTOO International Prostate Cancer Education & Support Network, Women Against Prostate Cancer, and ZERO - The Project to End Prostate Cancer.

About The V Foundation

The V Foundation for Cancer Research was founded in 1993 by ESPN and the late Jim Valvano, legendary North Carolina State basketball coach and ESPN commentator. Since 1993, The Foundation has raised more than $80 million to fund cancer research grants nationwide. It awards 100 percent of all new direct cash donations and net proceeds of events directly to cancer research and related programs. The Foundation, which has received five consecutive top 4-star ratings from Charity Navigator, awards grants through a competitive awards process strictly supervised by a Scientific Advisory Board.

About Stand Up to Cancer (SU2C)

Stand Up To Cancer is a program of the Entertainment Industry Foundation (EIF), a 501(c)(3) charitable organization, and was established by a group of media, entertainment and philanthropic leaders, whose lives have all been affected by cancer in significant ways.

About GlaxoSmithKline

GlaxoSmithKline - one of the world's leading research-based pharmaceutical and healthcare companies - is committed to improving the quality of human life by enabling people to do more, feel better and live longer.

Cautionary statement regarding forward-looking statements Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any for
'/>"/>

SOURCE The V Foundation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Triathlete Michael Hennessey Completes 15th Ironman Competition
2. Texas Super Dentist Awards Announced--Dr. Michael McCarty From Austin Smiles Is Awarded For The Third Year In A Row
3. BioTime CEO Dr. Michael West Announces the Launch of New Products and Discusses the State of the Stem Cell Industry under the Obama Administration at the Wisconsin Academy of Sciences, Arts, and Letters
4. Michael J. Fox Foundation Names Core Programs in Honor of Humanitarian Edmond J. Safra
5. Vocollect Healthcare Systems Names Michael French as Vice President of Customer Experience
6. UCSF Chancellor J. Michael Bishop Announces Plan To Step Down
7. Majesco Entertainment and Interactive Game Group Announce Jillian Michaels Fitness Ultimatum 2009 Ships to Stores October 21st
8. US Oncology Appoints Michael A. Sicuro Executive Vice President and Chief Financial Officer
9. Quorum Review IRB Appoints Michael Malafronte Director of Quality and Document Administration
10. Michael J. Fox Foundation Awards One Million Dollars for Development of Trojan Horse Delivery Technology to Treat Parkinsons Disease
11. Catholic Health East Acquires Saint Michaels Medical Center
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 2Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 3Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 4Sanofi Pasteur Global Dengue Vaccine Clinical Program Expanded in Latin America 5Ascension Orthopedics Hires Key Senior Executives 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 2Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 3Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 4Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 5Sangamo BioSciences Announces Presentation of Preliminary Data From Phase 2 Study of SB-509 at International ALS Symposium 6U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 1U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 2U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 3U S News Media Group and NCQA Release 2009 10 Rankings of Americas Best Health Insurance Plans 61224 4Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 1Fred Hassan Joins Bausch 26amp 3B Lomb Board of Directors 61219 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 1WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 2WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 3WaferGen Announces that University of Texas Southwestern Medical Center Demonstrates Utility of New SmartChip 28TM 29 Nano Dispenser with WaferGens Sm 14810 4